ValuEngine Upgrades CAS Medical Systems (CASM) to “Sell”

CAS Medical Systems (NASDAQ:CASM) was upgraded by research analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a report released on Friday.

Shares of CAS Medical Systems (CASM) opened at $1.19 on Friday. CAS Medical Systems has a fifty-two week low of $0.59 and a fifty-two week high of $1.63. The company has a market capitalization of $33.59, a price-to-earnings ratio of -8.50 and a beta of -0.57. The company has a current ratio of 2.46, a quick ratio of 2.12 and a debt-to-equity ratio of -0.56.

CAS Medical Systems (NASDAQ:CASM) last announced its quarterly earnings data on Thursday, November 9th. The medical technology company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.05. The business had revenue of $4.53 million during the quarter, compared to analysts’ expectations of $4.47 million. sell-side analysts anticipate that CAS Medical Systems will post -0.27 EPS for the current year.

TRADEMARK VIOLATION WARNING: “ValuEngine Upgrades CAS Medical Systems (CASM) to “Sell”” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/04/valuengine-upgrades-cas-medical-systems-casm-to-sell.html.

CAS Medical Systems Company Profile

CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.

Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply